Literature DB >> 18221912

Quasispecies as predictive factor of rapid, early and sustained virological responses in chronic hepatitis C, genotype 1, treated with peginterferon-ribavirin.

Javier Salmerón1, Jorge Casado, Paloma Muñoz de Rueda, Victor Lafuente, Moises Diago, Manuel Romero-Gómez, Angel Palacios, Josefa León, Ana Gila, Rosa Quiles, Luis Rodriguez, Angeles Ruiz-Extremera.   

Abstract

BACKGROUND: The relationship between the complexity of the hypervariable region 1 quasispecies of HCV and responsiveness to therapy is not completely clear.
OBJECTIVE: To investigate the importance of quasispecies as a predictive factor of rapid (RVR), early (EVR) and sustained (SVR) virologic response.
METHODS: Prospective analysis of 82 patients with chronic hepatitis C, genotype 1, treated with peginterferon alfa-2a and ribavirin. Quasispecies (SSCP), HCV-RNA and viral load were determined at baseline and 2, 4, 8 and 12 weeks after beginning treatment.
RESULTS: Less fibrosis and lower serum GGT activity were the only predictive factors for EVR. SVR predictive factors were age < or =40 years, viral load < or =600,000IU/mL, and quasispecies < or =5 bands. By logistic regression analysis, the independent factors determining SVR were age (P=0.011), viral load (P=0.027), and quasispecies (P=0.010). Quasispecies and viral load were not predictive factors of RVR. During treatment, quasispecies decreased rapidly in the SVR group. In non-EVR patients, quasispecies were slightly lower up to 8 weeks and then increased.
CONCLUSIONS: Quasispecies are an important predictive factor for SVR, but are no better predictors than viral load. Quasispecies are not predictive factors for RVR or EVR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18221912     DOI: 10.1016/j.jcv.2007.11.023

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  8 in total

1.  Impact of interferon-ribavirin treatment on hepatitis C virus (HCV) protease quasispecies diversity in HIV- and HCV-coinfected patients.

Authors:  Aarthi Chary; Mark A Winters; Shyam Kottilil; Alison A Murphy; Michael A Polis; Mark Holodniy
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

2.  IL28B polymorphism is not associated with HCV protease diversity in patients co-infected with HIV and HCV treated with pegylated interferon and ribavirin.

Authors:  Anu Osinusi; Aarthi Chary; Mark A Winters; Susanna Naggie; Henry Masur; Michael A Polis; Shyam Kottilil; Mark Holodniy
Journal:  J Med Virol       Date:  2012-10       Impact factor: 2.327

Review 3.  The quasispecies nature and biological implications of the hepatitis C virus.

Authors:  Sarah L Fishman; Andrea D Branch
Journal:  Infect Genet Evol       Date:  2009-08-08       Impact factor: 3.342

4.  Complexity and catalytic efficiency of hepatitis C virus (HCV) NS3 and NS4A protease quasispecies influence responsiveness to treatment with pegylated interferon plus ribavirin in HCV/HIV-coinfected patients.

Authors:  Ester Aparicio; Sandra Franco; Mariona Parera; Cristina Andrés; Cristina Tural; Bonaventura Clotet; Miguel Angel Martínez
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

5.  Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy.

Authors:  Ahmed A Al-Qahtani; George Kessie; Damian Dela Cruz; Faleh Z Al-Faleh; Mohammed N Al-Ahdal
Journal:  Ann Saudi Med       Date:  2010 Mar-Apr       Impact factor: 1.526

6.  Positional effect of mutations in 5'UTR of hepatitis C virus 4a on patients' response to therapy.

Authors:  Mostafa-K El Awady; Hassan-M Azzazy; Ahmed-M Fahmy; Sherif-M Shawky; Noha-G Badreldin; Samar-S Yossef; Moataza-H Omran; Abdel-Rahman-N Zekri; Said-A Goueli
Journal:  World J Gastroenterol       Date:  2009-03-28       Impact factor: 5.742

7.  Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.

Authors:  Kenneth E Sherman; Susan D Rouster; Sandra Stanford; Jason T Blackard; Norah Shire; Margaret Koziel; Marion Peters; Raymond T Chung
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226

8.  Dynamics of Genotypic Mutations of the Hepatitis B Virus Associated With Long-Term Entecavir Treatment Determined With Ultradeep Pyrosequencing: A Retrospective Observational Study.

Authors:  Xia-Xia Zhang; Min-Ran Li; Ying Cao; Ren-Wen Zhang; Yu Zhang; Fang Li; Hong-Li Xi; Xiao-Yuan Xu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.